NeuroTherapia (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- August 06, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $12,300,000
Company Info
- Founders
- Tony Giordano, Ph.D.
- Company Description
- NeuroTherapia is a clinical-stage, privately held biotechnology company developing oral, small-molecule drugs to address neuro-inflammatory conditions of the central nervous system (CNS), including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and other CNS conditions. The company is focused on therapeutics that inhibit microglia cells, which drive inflammation in the CNS, without affecting the clearance of toxic beta amyloid.
- Market
- Neuro-inflammatory conditions of the central nervous system
- Location
- Gates Hill, Ohio, USA
- Coinvestors
- Alzheimer's Drug Discovery Foundation, Brain Trust Accelerator Fund, Cleveland Clinic, CRUINT, Dolby Family Ventures, Foundation for a Better World